Related Experiment Videos
Long-term central venous catheterization via persistent left superior vena cava: a case report
Lamberto Laurenzi1, Sebastiano Natoli, Lorella Pelagalli
1Department of Pain Therapy and Palliative Care, "Regina Elena" National Cancer Institute, Via Elio Chianesi, 53, 00141 Rome, Italy.
Summary
A rare persistent left superior vena cava (PLSVC) anomaly was identified in a cancer patient post-central venous catheter (Port-a-Cath) implantation. The catheter remained safely in situ for 8 months, indicating acceptable risk in similar cases.
Area of Science:
- Cardiology
- Vascular Surgery
- Oncology
Background:
- Persistent left superior vena cava (PLSVC) is a rare congenital anomaly.
- Central venous catheters (Port-a-Cath) are crucial for long-term chemotherapy administration.
- Data on managing indwelling devices in patients with PLSVC is limited.
Observation:
- A cancer patient with PLSVC was diagnosed with a Port-a-Cath via angiography.
- The anomaly did not preclude the safe use of the implanted device.
- The patient received 8 months of chemotherapy and supportive care.
Findings:
- No complications related to the central venous catheter were observed during the treatment period.
- The venous caliber was deemed adequate for catheter function.
- The patient's critical condition necessitated the use of the catheter despite the anomaly.
Implications:
- This case suggests that central venous catheter implantation in patients with PLSVC may be feasible and safe.
- Careful monitoring is essential when managing such cases.
- Further research is warranted to establish definitive guidelines for device management in PLSVC patients.